The Business Research Company’s latest report Metabolic Disorders Drugs Global Market Report 2020 covers Metabolic Disorders Drugs market drivers, Metabolic Disorders Drugs market trends, Metabolic Disorders Drugs market segments, Metabolic Disorders Drugs market growth rate, Metabolic Disorders Drugs market major players, and Metabolic Disorders Drugs market size. The report provides in-depth analysis of the impact of COVID-19 on the Metabolic Disorders Drugs industry, along with revised market numbers due to the effects of the coronavirus.
View Complete Report:
Metabolic Disorders Drugs Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
Request for the sample now:
The global metabolic disorders drugs market is expected to decline from $145.9 billion in 2019 to $141.4 billion in 2020 at a compound annual growth rate (CAGR) of -3.1%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. The COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 8% from 2021 and reach $200.8 billion in 2023.
The report covers the Metabolic Disorders Drugs market’s segments-
1) By Type: Anti Diabetics drugs, Anti-Thyroid drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism).
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
3) By Route Of Administration: Oral, Parenteral, Others.
4) By Drug Classification: Branded Drugs, Generic Drugs.
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
TBRC’s annual festive sale is finally here! Get up to 50% off on ALL reports: https://www.thebusinessresearchcompany.com/global-market-reports
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 20 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]